Journal
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
Volume 23, Issue -, Pages 263-264Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.jgar.2020.09.030
Keywords
Ototoxicity; Prevention; SARS-CoV-2 (Covid-19); Chloroquine; Hydroxychloroquine
Categories
Ask authors/readers for more resources
Aim of this paper is to remind the risk of ototoxicity when using chloroquine and hydroxychloroquine, in particular as prophylactic agents against SARS-CoV-2, during the pandemic. Healthy subjects taking chloroquine and hydroxychloroquine as prophylactic agents against SARS-CoV-2, during the pandemic, should be screened periodically, at least by Otoacoustic Emissions (OAEs) in order to detect early manifestations of possible cochlear ototoxic damages. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available